Mass

Champion of Justice: Meet Brendan A. Smith, a Leading Voice in Mass Tort and Product Liability Law

by

St. Louis, Mo. — Brendan A. Smith, an award-winning attorney with over ten years of experience in complex litigation, has made significant strides in the arenas of pharmaceutical, medical device, and sexual abuse litigation. Operating out of the St. Louis office of Simmons Hanly Conroy, Smith has dedicated his career to advocating for individuals who have suffered due to unsafe products. At the heart of Smith’s legal practice is a drive to take on major national and multinational companies, ensuring they are held accountable for their actions. His efforts, along with his team, have culminated … Read more

Motley Rice Bolsters Philadelphia Team with New Hire, Aiming for Deeper Collaboration in Mass Torts Arena

by

Philadelphia, PA – The legal landscape in Philadelphia is set to change with the addition of Michael Daly, a prominent mass tort attorney, to the team at Motley Rice LLC. Daly, who previously led the Philadelphia office of Pogust Goodhead, has been appointed to enhance Motley Rice’s local operations amidst significant ongoing litigations, including the Ozempic and Roundup cases. According to Motley Rice, Daly’s arrival marks a significant expansion in Philadelphia, supplementing its robust team across the nearby Cherry Hill, New Jersey office. Donald Migliori, a member of the firm’s executive board and a trial … Read more

Exploring Legal Strategies for GLP-1 Weight-Loss Drug Manufacturers in the U.S. Mass Tort Arena

by

New York — As the rates of obesity continue to climb at an alarming rate worldwide, pharmaceutical companies have intensified their efforts in advancing medications targeted at weight management. Among these, glucagon-like peptide-1 receptor (GLP-1) weight-loss drugs have been gaining attention not just for their efficacy but also for the litigation challenges they may face. Historically, the American mass tort litigation landscape offers extensive insights that are invaluable for these manufacturers in navigating potential legal battles. In the U.S., mass tort claims have frequently emerged in the pharmaceutical sector, with companies often finding themselves entangled … Read more

Supreme Court Rules on Insurance Neutrality: What Debtors Need to Know About Insurer Challenges in Mass Tort Bankruptcies

by

Washington — A recent Supreme Court ruling has set the stage for significant transformations in the handling of insurance claims within mass tort bankruptcies. In a decision that underscores the need for debtors to be more vigilant, the court sided with insurers, demanding that claims be treated with stricter scrutiny to prevent potential inequities. This new judgment addresses the often contentious issue of “insurance neutrality,” a legal stance where bankruptcy filings should not affect the handling of insurance claims. Previously, companies under mass tort claims, such as those associated with asbestos-related liabilities or large-scale product … Read more